Series EditorsProf. Maurizio Cecconi is Head of Department Anaesthesia and Intensive Care Units, IRCCS Istituto Clinico Humanitas, Rozzano (MI), Italy and Professor of Anaesthesia and Intensive Care, Humanitas University, Pieve Emanuele (MI), Italy. His main fields of research are haemodynamic monitoring, haemodynamic optimisation and physiology of the critically ill patient. He has published extensively and has specific interest in haemodynamic monitoring and fluid management of the critically ill.Prof. Daniel De Backer is Professor of Intensive Care at the Université Libre de Bruxelles, Brussels, Belgium Head of Intensive Care Departments of CHIREC Hospitals (Brussels and Braine l’Alleud-Waterloo). His main fields of investigation are severe sepsis, organ dysfunction, acute circulatory failure and its treatment (in particular vasoactive agents), haemodynamic monitoring, hepato-splanchnic circulation and microcirculatorydisorders.Volume EditorsZsolt Molnar is a professor in anaesthesiology and intensive therapy. Currently he holds a full professorship at the Department of Anaesthesiology and Intensive Therapy, Semmelweis University, Budapest, Hungary and a part time professorship at the Department of Anaesthesiology and Intensive Therapy at the Poznan University of Medical Sciences, Poznan, Poland. He is also a Senior Medical Director at CytoSorbents Europe, Berlin, Germany. He has published extensively in the fields of sepsis related hemodynamic changes, fluid therapy, markers of inflammation, extracorporeal cytokine removal in hyperinflammation, oxygen debt and perioperative intensive care.Marlies Ostermann is a Professor of Intensive Care and consultant in critical care and nephrology at Guy’s and St Thomas’ NHS Foundation Trust, London. She is also the departmental Research and Delivery lead and Director of Research of the Intensive Care Society,UK. Her research interest focusses on all aspects of acute kidney injury (kidney failure) and critical care nephrology. Manu Shankar-Hari is Chair of Translational Critical Care Medicine at The University of Edinburgh, Edinburgh, UK. Manu's research programme aims to enable precision immunomodulation in critically ill adults with sepsis and acute respiratory distress syndrome (ARDS).
